CIK: 0001536411 · Show all filings
Period: Q2 2013 (Next →)
Filing Date: Aug 14, 2013
Total Value ($000): $673,764 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Google Inc. | 223,250 | $196,543 | 29.2% | $880.37 | — | CL A | 38259P508 |
| — | CBS Corp | 2,044,000 | $99,890 | 14.8% | $48.87 | — | CL B | 124857202 |
| DAL | Delta Air Lines Inc. | 3,861,500 | $72,249 | 10.7% | $14.99 | 0.0% | COM | 247361702 |
| PG | Procter & Gamble Co | 566,300 | $43,599 | 6.5% | $55.00 | 0.0% | COM | 742718109 |
| — | US Airways Group Inc. | 2,364,000 | $38,817 | 5.8% | $16.42 | — | COM | 90341W108 |
| — | Charter Comm's Inc | 272,000 | $33,687 | 5.0% | $123.85 | — | CL A | 16117M305 |
| WDAY | Workday Inc. | 505,500 | $32,397 | 4.8% | $62.77 | 0.0% | CL A | 98138H101 |
| GILD | Gilead Sciences Inc. | 610,700 | $31,311 | 4.6% | $36.21 | 0.0% | COM | 375558103 |
| VZ | Verizon Comm's Inc. | 473,000 | $23,811 | 3.5% | $27.04 | 0.0% | COM | 92343V104 |
| — | Cubist Pharms Inc. | 413,000 | $19,944 | 3.0% | $48.29 | — | COM | 229678107 |
| BIIB | Biogen Idec Inc. | 91,500 | $19,691 | 2.9% | $213.68 | 0.0% | COM | 09062X103 |
| LYB | LyondellBasell Ind's NV | 218,000 | $14,445 | 2.1% | $33.34 | 0.0% | SHS - A | N53745100 |
| JNJ | Johnson & Johnson | 129,000 | $11,076 | 1.6% | $59.66 | 0.0% | COM | 478160104 |
| XLF | Select Sector SPDR TR | 544,700 | $10,616 | 1.6% | $19.49 | — | SBI INT-FINL | 81369Y605 |
| BA | Boeing Co | 99,200 | $10,162 | 1.5% | $80.37 | 0.0% | COM | 097023105 |
| BSX | Boston Scientific Corp | 1,000,000 | $9,270 | 1.4% | $8.48 | 0.0% | COM | 101137107 |
| XLK | Select Sector SPDR TR | 204,500 | $6,256 | 0.9% | $30.59 | — | TECHNOLOGY | 81369Y803 |